Mostrar el registro sencillo del ítem

dc.contributor.author
Sacerdoti, Flavia  
dc.contributor.author
Romero, Edith  
dc.contributor.author
Amaral, María Marta  
dc.contributor.author
Ibarra, Cristina Adriana  
dc.date.available
2023-04-12T16:06:36Z  
dc.date.issued
2020  
dc.identifier.citation
Neutralizing properties of human milk against shiga toxin type 2; LXV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LXVIII Reunión Anual de la Sociedad Argentina de Inmunología y Reunión Anual de la Sociedad Argentina de Fisiología; Argentina; 2020; 86-86  
dc.identifier.uri
http://hdl.handle.net/11336/193505  
dc.description.abstract
Shiga toxin (Stx) producing Escherichia coli (STEC) is a foodborne pathogen responsible for Hemolytic Uremic Sindrome (HUS). Stx is the main virulence factor responsible for this disease and Stx type 2 (Stx2) has been associated with more severe cases affecting mainly children under 5 years of age. Breastfeeding is one of the least cost-effective public health tools to protect the newborn from diarrhea and its effectiveness can be attributed to different bioactive compounds transmitted through milk. We have previously demonstrated that rats immunized against Stx2 can transfer through lactation protection against a lethal dose of Stx2 to their offspring. In thiswork we aim to evaluate whether human milk from human healthy donors may have protective properties against Stx2. Human milks (n=107) were collected under informed consent at the National Hospital Prof. Alejandro Posadas by the manual method from healthywomen (18-45 years). After collection, milks were stored at 20°C until used. Milks were delipidated by centrifugation at 3000 rpm for 45 min. Supernatant was collected from samples and used for the evaluation of: 1) Neutralizing capacity of Stx2 in vitro on Vero cells, 2) Total protein content by the BCA kit 3) Total IgA content by radial immunodiffusion (RID) and 4) Ig Anti STEC titer by ELISA. Collected milk samples showed a mean of 229 mg/dL of total IgA levels (range: 10-675 mg/dL). Total protein content of samples was heterogeneous and ranged from 5.5 to 166.5 mg/ml. Fourteen milksamples (14/107; 13%) showed neutralizing properties against Stx2 in vitro. When comparing IgA levels and protein content of positive and negative samples for Stx2 neutralization, no significative differences were observed. Neutralizing capacity of Stx2 has no correlation with high Ig titer against STEC. These results indicate that some human milk may have neutralizing properties against Stx2. These data may be important for HUS prevention of newborn by promoting breastfeeding.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Fundación Revista Medicina  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
TOXINA SHIGA  
dc.subject
LECHE MATERNA  
dc.subject
INFECCIONES  
dc.subject
PROTECCION  
dc.subject.classification
Enfermedades Infecciosas  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Neutralizing properties of human milk against shiga toxin type 2  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.type
info:eu-repo/semantics/conferenceObject  
dc.type
info:ar-repo/semantics/documento de conferencia  
dc.date.updated
2023-01-09T13:53:56Z  
dc.journal.pagination
86-86  
dc.journal.pais
Argentina  
dc.journal.ciudad
Buenos Aires  
dc.description.fil
Fil: Sacerdoti, Flavia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Fisiología y Biofísica Bernardo Houssay. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiología y Biofísica Bernardo Houssay; Argentina  
dc.description.fil
Fil: Romero, Edith. Hospital Nacional Profesor Alejandro Posadas; Argentina  
dc.description.fil
Fil: Amaral, María Marta. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Fisiología y Biofísica Bernardo Houssay. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiología y Biofísica Bernardo Houssay; Argentina  
dc.description.fil
Fil: Ibarra, Cristina Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Fisiología y Biofísica Bernardo Houssay. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiología y Biofísica Bernardo Houssay; Argentina  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.saic.org.ar/reunion-anual  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.coverage
Nacional  
dc.type.subtype
Reunión  
dc.description.nombreEvento
LXV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LXVIII Reunión Anual de la Sociedad Argentina de Inmunología y Reunión Anual de la Sociedad Argentina de Fisiología  
dc.date.evento
2020-11-10  
dc.description.paisEvento
Argentina  
dc.type.publicacion
Journal  
dc.description.institucionOrganizadora
Sociedad Argentina de Investigación Clínica  
dc.description.institucionOrganizadora
Sociedad Argentina de Inmunologia  
dc.description.institucionOrganizadora
Sociedad Argentina de Fisiologia  
dc.source.revista
Medicina (Buenos Aires)  
dc.date.eventoHasta
2020-11-13  
dc.type
Reunión